Cargando…
Price Elasticity and Medication Use: Cost Sharing Across Multiple Clinical Conditions
BACKGROUND: To address the impact that out-of-pocket prices may have on medication use, it is vital to understand how the demand for medications may be affected when patients are faced with changes in the price to acquire treatment and how price responsiveness differs across medication classes. OBJE...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441015/ https://www.ncbi.nlm.nih.gov/pubmed/25351971 http://dx.doi.org/10.18553/jmcp.2014.20.11.1102 |
_version_ | 1785093282392440832 |
---|---|
author | Gatwood, Justin Gibson, Teresa B. Chernew, Michael E. Farr, Amanda M. Vogtmann, Emily Fendrick, A. Mark |
author_facet | Gatwood, Justin Gibson, Teresa B. Chernew, Michael E. Farr, Amanda M. Vogtmann, Emily Fendrick, A. Mark |
author_sort | Gatwood, Justin |
collection | PubMed |
description | BACKGROUND: To address the impact that out-of-pocket prices may have on medication use, it is vital to understand how the demand for medications may be affected when patients are faced with changes in the price to acquire treatment and how price responsiveness differs across medication classes. OBJECTIVES: To examine the impact of cost-sharing changes on the demand for 8 classes of prescription medications. METHODS: This was a retrospective database analysis of 11,550,363 commercially insured enrollees within the 2005-2009 MarketScan Database. Patient cost sharing, expressed as a price index for each medication class, was the main explanatory variable to examine the price elasticity of demand. Negative binomial fixed effect models were estimated to examine medication fills. The elasticity estimates reflect how use changes over time as a function of changes in copayments. RESULTS: Model estimates revealed that price elasticity of demand ranged from -0.015 to -0.157 within the 8 categories of medications (P less than 0.01 for 7 of 8 categories). The price elasticity of demand for smoking deterrents was largest (-0.157, P less than 0.0001), while demand for antiplatelet agents was not responsive to price (P greater than 0.05). CONCLUSIONS: The price elasticity of demand varied considerably by medication class, suggesting that the influence of cost sharing on medication use may be related to characteristics inherent to each medication class or underlying condition. |
format | Online Article Text |
id | pubmed-10441015 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Academy of Managed Care Pharmacy |
record_format | MEDLINE/PubMed |
spelling | pubmed-104410152023-08-21 Price Elasticity and Medication Use: Cost Sharing Across Multiple Clinical Conditions Gatwood, Justin Gibson, Teresa B. Chernew, Michael E. Farr, Amanda M. Vogtmann, Emily Fendrick, A. Mark J Manag Care Pharm Research BACKGROUND: To address the impact that out-of-pocket prices may have on medication use, it is vital to understand how the demand for medications may be affected when patients are faced with changes in the price to acquire treatment and how price responsiveness differs across medication classes. OBJECTIVES: To examine the impact of cost-sharing changes on the demand for 8 classes of prescription medications. METHODS: This was a retrospective database analysis of 11,550,363 commercially insured enrollees within the 2005-2009 MarketScan Database. Patient cost sharing, expressed as a price index for each medication class, was the main explanatory variable to examine the price elasticity of demand. Negative binomial fixed effect models were estimated to examine medication fills. The elasticity estimates reflect how use changes over time as a function of changes in copayments. RESULTS: Model estimates revealed that price elasticity of demand ranged from -0.015 to -0.157 within the 8 categories of medications (P less than 0.01 for 7 of 8 categories). The price elasticity of demand for smoking deterrents was largest (-0.157, P less than 0.0001), while demand for antiplatelet agents was not responsive to price (P greater than 0.05). CONCLUSIONS: The price elasticity of demand varied considerably by medication class, suggesting that the influence of cost sharing on medication use may be related to characteristics inherent to each medication class or underlying condition. Academy of Managed Care Pharmacy 2014-11 /pmc/articles/PMC10441015/ /pubmed/25351971 http://dx.doi.org/10.18553/jmcp.2014.20.11.1102 Text en Copyright © 2014, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Research Gatwood, Justin Gibson, Teresa B. Chernew, Michael E. Farr, Amanda M. Vogtmann, Emily Fendrick, A. Mark Price Elasticity and Medication Use: Cost Sharing Across Multiple Clinical Conditions |
title | Price Elasticity and Medication Use: Cost Sharing Across Multiple Clinical Conditions |
title_full | Price Elasticity and Medication Use: Cost Sharing Across Multiple Clinical Conditions |
title_fullStr | Price Elasticity and Medication Use: Cost Sharing Across Multiple Clinical Conditions |
title_full_unstemmed | Price Elasticity and Medication Use: Cost Sharing Across Multiple Clinical Conditions |
title_short | Price Elasticity and Medication Use: Cost Sharing Across Multiple Clinical Conditions |
title_sort | price elasticity and medication use: cost sharing across multiple clinical conditions |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441015/ https://www.ncbi.nlm.nih.gov/pubmed/25351971 http://dx.doi.org/10.18553/jmcp.2014.20.11.1102 |
work_keys_str_mv | AT gatwoodjustin priceelasticityandmedicationusecostsharingacrossmultipleclinicalconditions AT gibsonteresab priceelasticityandmedicationusecostsharingacrossmultipleclinicalconditions AT chernewmichaele priceelasticityandmedicationusecostsharingacrossmultipleclinicalconditions AT farramandam priceelasticityandmedicationusecostsharingacrossmultipleclinicalconditions AT vogtmannemily priceelasticityandmedicationusecostsharingacrossmultipleclinicalconditions AT fendrickamark priceelasticityandmedicationusecostsharingacrossmultipleclinicalconditions |